Prediction Models for Brain Distribution of Drugs Based on Biomimetic Chromatographic Data

Area of Science:

• Pharmacology
• Computational Chemistry
• Biomaterials Science

Background:

• Accurate prediction of drug distribution in the brain is vital for early-stage drug screening.
• The blood-brain barrier (BBB) and complex tissue binding present significant challenges for in silico modeling.
• Existing computational models often neglect plasma and tissue binding, focusing solely on permeability.

Purpose of the Study:

• To develop robust in silico models for estimating drug brain disposition.
• To integrate experimental data from biomimetic chromatography with molecular descriptors.
• To improve the early evaluation of central nervous system (CNS) drug candidates.

Main Methods:

• Utilized High-Performance Liquid Chromatography (HPLC) with biomimetic columns (immobilized artificial membranes, human serum albumin, α1-acid glycoprotein).
• Combined experimental chromatographic data with molecular descriptors to model drug brain disposition.
• Collected literature data for unbound brain-to-plasma concentration ratio (Kp,uu,brain), brain permeability, unbound fraction in the brain, and unbound volume of distribution in the brain.

Main Results:

• Developed models with high statistical quality (R2 > 0.6) for brain disposition.
• Achieved excellent performance (R2 > 0.9) for models predicting the unbound fraction in the brain.
• Validated all models and estimated their applicability domains.

Conclusions:

• Emphasized the critical roles of phospholipid, tissue, and protein binding alongside BBB permeability in drug brain disposition.
• Demonstrated biomimetic chromatography as an effective, rapid technique for generating experimental data.
• Proposed this approach for constructing evidence-based models for early CNS drug candidate assessment.